Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | iSTOXX® FactSet Breakthrough Healthcare |
| Investment focus | Equity, World, Health Care, Social/Environmental |
| Fund size | EUR 920 m |
| Total expense ratio | 0.40% p.a. |
| Replication | Physical (Optimized sampling) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | Yes |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 16.07% |
| Inception/ Listing Date | 8 September 2016 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | iShares |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | State Street Fund Services (Ireland) Limited |
| Investment Advisor | |
| Custodian Bank | State Street Custodial Services (Ireland) Limited |
| Revision Company | Deloitte |
| Fiscal Year End | 31 May |
| Swiss representative | BlackRock Asset Management Schweiz AG |
| Swiss paying agent | State Street Bank International GmbH, Munich, Zurich Branch |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | Bank of New York Mellon|Euroclear|JP Morgan|State Street Bank |
| Securities lending | Yes |
| Securities lending counterparty | Barclays Bank Plc|Barclays Capital Securities Ltd.|BNP Paribas Arbitrage SNC|BNP Paribas SA|Citigroup Global Markets Ltd|Citigroup Inc|Credit Suisse Securities (Europe) Ltd.|Deutsche Bank AG|Goldman Sachs International|HSBC Bank Plc|J.P. Morgan Securities Plc|JP Morgan Chase & Co|Macquarie Bank Limited|Merrill Lynch International|Morgan Stanley & Co. International Plc|Nomura International Plc|Skandinaviska Enskilda Banken AB|Societe Generale SA|The Bank of Nova Scotia|UBS AG |
| UCB SA | 2.17% |
| IQVIA Holdings | 2.02% |
| Thermo Fisher Scientific | 2.00% |
| Genmab A/S | 1.85% |
| Johnson & Johnson | 1.80% |
| AbbVie, Inc. | 1.79% |
| Agilent Technologies | 1.77% |
| BeOne Medicines Ltd. | 1.75% |
| Natera | 1.74% |
| GSK Plc | 1.71% |
| United States | 62.07% |
| Switzerland | 5.06% |
| South Korea | 4.29% |
| Japan | 3.81% |
| Other | 24.77% |
| Health Care | 90.35% |
| Technology | 2.32% |
| Other | 7.34% |
| YTD | +6.57% |
| 1 month | +5.27% |
| 3 months | +12.25% |
| 6 months | +17.85% |
| 1 year | +3.04% |
| 3 years | +5.99% |
| 5 years | -2.14% |
| Since inception (MAX) | +74.66% |
| 2024 | +7.98% |
| 2023 | -1.46% |
| 2022 | -18.99% |
| 2021 | +1.80% |
| Volatility 1 year | 16.08% |
| Volatility 3 years | 15.36% |
| Volatility 5 years | 18.42% |
| Return per risk 1 year | 0.20 |
| Return per risk 3 years | 0.12 |
| Return per risk 5 years | -0.01 |
| Maximum drawdown 1 year | -21.98% |
| Maximum drawdown 3 years | -22.04% |
| Maximum drawdown 5 years | -38.72% |
| Maximum drawdown since inception | -38.72% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | 2B78 | - - | - - | - |
| Stuttgart Stock Exchange | EUR | 2B78 | - - | - - | - |
| Bolsa Mexicana de Valores | MXN | - | HEALN MM | HEALN.MX | |
| Borsa Italiana | EUR | HEAL | HEAL IM INAVHEAE | HEAL.MI | |
| Euronext Amsterdam | EUR | HEAL | HEAL NA | ||
| London Stock Exchange | GBX | DRDR | DRDR LN | DRDR.L | |
| London Stock Exchange | USD | HEAL | HEAL LN INAVHEAU | HEAL.L 0O64INAV.DE | |
| London Stock Exchange | GBP | - | DRDR LN INAVHEAG | DRDR.L 0O62INAV.DE | |
| SIX Swiss Exchange | USD | HEAL | HEAL SE INAVHEAU | HEAL.S 0O64INAV.DE | |
| XETRA | EUR | 2B78 | 2B78 GY INAVHEAE | 2B78.DE 0O60INAV.DE |